Patents by Inventor Shira Walach

Shira Walach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING, AND ASSAYS AND METHODS OF USE THEREOF
    Publication number: 20100189652
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: April 12, 2010
    Publication date: July 29, 2010
    Inventors: SARAH POLLOCK, ANAT COHEN-DAYAG, OSNAT SELLA-TAVOR, SHIRLEY SAMEAH-GREENWALD, SHIRA WALACH, LILY BAZAK
  • Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
    Patent number: 7741433
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 22, 2010
    Assignee: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of use Thereof for Diagnosis of Ovarian Cancer
    Publication number: 20100124786
    Abstract: Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 20, 2010
    Applicant: Compugen LTD
    Inventors: Gad S. Cojocaru, Sarah Pollock, Zurit Levine, Alexander Diber, Guy Kol, Amir Toporik, Rotem Sorek, Dvir Dahary, Michal Ayalon-Soffer, Pinchas Akiva, Amit Novik, Yossi Cohen, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Maxim Shklar
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
    Patent number: 7714100
    Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: May 11, 2010
    Assignee: Compugen LTD
    Inventors: Yossi Cohen, Alexander Diber, Amir Toporik, Sarah Pollock, Zurit Levine, Michal Ayalon-Soffer, Gad S. Cojocaru, Amit Novik, Guy Kol, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Dvir Dahary, Ronen Shemesh
  • Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
    Publication number: 20100068736
    Abstract: Novel markers for lung cancer that are both sensitive and accurate. These markers are overexpressed in lung cancer specifically, as opposed to normal lung tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of lung cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between lung cancer and non-cancerous states.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 18, 2010
    Applicant: Compugen LTD.
    Inventors: Sarah Pollock, Zurit Levine, Amit Novik, Dvir Dahary, Rotem Sorek, Amir Toporik, Shirley Sameah-Greenwald, Osnat Sella-Tavor, Alexander Diber, Gad S. Cojocaru, Michal Ayalon-Soffer, Shira Walach, Pinchas Akiva, Naomi Keren, Ronen Shemesh
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
    Patent number: 7667001
    Abstract: Novel markers for lung cancer that are both sensitive and accurate. These markers are overexpressed in lung cancer specifically, as opposed to normal lung tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of lung cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between lung cancer and non-cancerous states.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 23, 2010
    Assignee: Compugen Ltd.
    Inventors: Sarah Pollock, Zurit Levine, Amit Novik, Dvir Dahary, Rotem Sorek, Amir Toporik, Shirley Sameah-Greenwald, Osnat Sella-Tavor, Alexander Diber, Gad S. Cojocaru, Michal Avalon-Soffer, Shira Walach, Pinchas Akiva, Naomi Keren, Ronen Shemesh
  • NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF BREAST CANCER
    Publication number: 20090286957
    Abstract: Novel markers for breast cancer that are both sensitive and accurate. These markers are overexpressed in breast cancer specifically, as opposed to normal breast tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of breast cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between breast cancer and non-cancerous states.
    Type: Application
    Filed: January 8, 2009
    Publication date: November 19, 2009
    Applicant: Compugen LTD
    Inventors: Amir Toporik, Dvir Dahary, Rotem Sorek, Sarah Pollock, Zurit Levine, Pinchas Akiva, Alexander Diber, Amit Novik, Osnat Sella-Tavor, Michal Ayalon-Soffer, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Naomi Keren, Maxim Shklar
  • Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
    Publication number: 20090215046
    Abstract: Novel markers for colon cancer that are both sensitive and accurate. These markers are overexpressed in colon cancer specifically, as opposed to normal colon tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of colon cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between colon cancer and non-cancerous states.
    Type: Application
    Filed: October 23, 2007
    Publication date: August 27, 2009
    Applicant: COMPUGEN LTD.
    Inventors: Rotem Sorek, Michal Ayalon-Soffer, Dvir Dahary, Amit Novik, Amir Toporik, Alexander Diber, Guy Kol, Sarah Pollock, Zurit Levine, Gad S. Cojocaru, Ronen Shemesh, Yossi Cohen, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach
  • NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING AND ASSAYS AND METHODS OF USE THEREOF
    Publication number: 20090202991
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: October 30, 2007
    Publication date: August 13, 2009
    Inventors: Sarah POLLOCK, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
    Patent number: 7569662
    Abstract: Novel markers for lung cancer that are both sensitive and accurate. These markers are overexpressed in lung cancer specifically, as opposed to normal lung tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of lung cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between lung cancer and non-cancerous states.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: August 4, 2009
    Assignee: Compugen Ltd
    Inventors: Sarah Pollock, Zurit Levine, Amit Novik, Dvir Dahary, Rotem Sorek, Amir Toporik, Shirley Sameah-Greenwald, Osnat Sella-Tavor, Alexander Diber, Gad S. Cojocaru, Michal Ayalon-Soffer, Shira Walach, Pinchas Akiva, Naomi Keren, Ronen Shemesh
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
    Patent number: 7553948
    Abstract: Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: June 30, 2009
    Assignee: Compugen Ltd
    Inventors: Gad S. Cojocaru, Sarah Pollock, Zurit Levine, Alexander Diber, Guy Kol, Amir Toporik, Rotem Sorek, Dvir Dahary, Michal Ayalon-Soffer, Pinchas Akiva, Amit Novik, Yossi Cohen, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Maxim Shklar
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
    Patent number: 7528243
    Abstract: Novel markers for breast cancer that are both sensitive and accurate. These markers are overexpressed in breast cancer specifically, as opposed to normal breast tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of breast cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between breast cancer and non-cancerous states.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: May 5, 2009
    Assignee: Compugen Ltd
    Inventors: Amir Toporik, Dvir Dahary, Rotem Sorek, Sarah Pollock, Zurit Levine, Pinchas Akiva, Alexander Diber, Amit Novik, Osnat Sella-Tavor, Michal Ayalon-Soffer, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Naomi Keren, Maxim Shklar
  • NOVEL NUCLEIC ACID SEQUENCES AND METHODS OF USE THEREOF FOR DIAGNOSIS
    Publication number: 20090075257
    Abstract: Novel splice variant nucleic acid and amino acid sequences are provided. The novel splice variants and their nucleic acid sequences may be used for diagnosis of variant-detectable diseases particularly cancerous diseases.
    Type: Application
    Filed: July 31, 2007
    Publication date: March 19, 2009
    Applicant: Compugen Ltd.
    Inventors: Sarah Pollock, Osnat Sella-Tavor, Amit Novik, Elena Tsypkin, Dan Sztybel, Shira Walach
  • Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
    Patent number: 7488813
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: February 10, 2009
    Assignee: Compugen, Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
    Publication number: 20090004648
    Abstract: Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.
    Type: Application
    Filed: March 6, 2007
    Publication date: January 1, 2009
    Applicant: COMPUGEN LTD.
    Inventors: Gad S. Cojocaru, Sarah Pollock, Zurit Levine, Alexander Diber, Guy Kol, Amir Toporik, Rotem Sorek, Dvir Dahary, Michal Ayalon-Soffer, Pinchas Akiva, Amit Novik, Yossi Cohen, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Maxim Shklar
  • Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
    Publication number: 20080193941
    Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
    Type: Application
    Filed: October 29, 2007
    Publication date: August 14, 2008
    Applicant: COMPUGEN LTD.
    Inventors: Yossi Cohen, Alexander Diber, Amir Toporik, Sarah Pollock, Zurit Levine, Michal Avalon-Soffer, Gad S. Cojocaru, Amit Novik, Guy Kol, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Dvir Dahary, Ronen Shemesh
  • Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
    Patent number: 7345142
    Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: March 18, 2008
    Assignee: Compugen Ltd.
    Inventors: Yossi Cohen, Alexander Diber, Amir Toporik, Sarah Pollock, Zurit Levine, Michal Ayalon-Soffer, Gad S. Cojocaru, Amit Novik, Guy Kol, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Dvir Dahary, Ronen Shemesh
  • Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
    Publication number: 20070259386
    Abstract: Novel markers for breast cancer that are both sensitive and accurate. These markers are overexpressed in breast cancer specifically, as opposed to normal breast tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of breast cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between breast cancer and non-cancerous states.
    Type: Application
    Filed: February 28, 2007
    Publication date: November 8, 2007
    Applicant: COMPUGEN LTD.
    Inventors: Amir Toporik, Dvir Dahary, Rotem Sorek, Sarah Pollock, Zurit Levine, Pinchas Akiva, Alexander Diber, Amit Novik, Osnat Sella-Tayor, Michal Ayalon-Soffer, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Naomi Keren, Maxim Shklar
  • Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
    Publication number: 20060263786
    Abstract: Novel markers for colon cancer that are both sensitive and accurate. These markers are overexpressed in colon cancer specifically, as opposed to normal colon tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of colon cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between colon cancer and non-cancerous states.
    Type: Application
    Filed: January 27, 2005
    Publication date: November 23, 2006
    Inventors: Rotem Sorek, Michal Ayalon-Soffer, Dvir Dahary, Amit Novik, Amir Toporik, Alexander Diber, Guy Kol, Sarah Pollock, Zurit Levine, Gad Coiocaru, Ronen Shemesh, Yossi Cohen, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach
  • Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
    Publication number: 20060257896
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: February 24, 2006
    Publication date: November 16, 2006
    Applicant: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak